Why is Ajooni Biotech falling/rising?

As of 04-Sep, Ajooni Biotech Ltd's stock price is currently at Rs 5.24, reflecting an increase of Rs 0.05 or 0.96%. Despite this slight uptick, the stock has been underperforming in the longer term, with a one-week return of -2.78% and a one-month return of -4.20%. The stock is trading lower than its moving averages across all time frames, indicating a bearish trend. Additionally, the delivery volume has decreased by 11.6% compared to the five-day average, suggesting a decline in investor participation. On a positive note, the company has reported strong financial results over the last four quarters, with a significant growth in net sales and profits, which may provide some support for the stock.
In the broader market context, Ajooni Biotech's performance has lagged behind the Sensex, which has gained 0.95% over the past week. The stock's year-to-date return of -32.56% starkly contrasts with the Sensex's positive return of 4.61%, highlighting its struggles in comparison to the overall market. While the company has attractive valuations and a low PEG ratio, its weak long-term fundamentals, including a low return on capital employed and poor debt servicing ability, contribute to a negative outlook. This combination of factors suggests that while there may be short-term gains, the long-term prospects remain concerning, leading to a cautious sentiment among investors.